Tanvex BioPharma, Inc. announced that at its annual general shareholders meeting held on June 19, 2024, approved the change of directors. Title and name of the previous position holder: Chang, Chun-Yen/Independent Director. Resume of the previous position holder: Chang, Chun-Yen/Independent Director.

Title and name of the new position holder: Chang, Chi-feng/Independent Director; Hsieh, Shang-Hsien/Independent Director. Resume of the new position holder: Chang, Chi-feng/Independent Director StemBios Technologies, Inc. Director; Hsieh, Shang-Hsien/Independent Director Professor, Department of Civil Engineering, NTU. Effective date of the new appointment is June 19, 2024.